For Lupus Awareness Month in May, NBC12 hosted a Digital Dialogue Tuesday night featuring advocates and specialists in the Lupus field, treatment, coping with the disease, finding a cure and new advancements being pioneered right here in Virginia. The Dialogue included AMPEL COO & CSO, Dr Amrie Grammer.
Watch the full program with host Kelly Avellino here: https://www.nbc12.com/2019/05/24/digital-dialogue-lupus-awareness-month/
Rheumatologists lack a definitive diagnostic tool to determine whether a patient has systemic lupus erythematous (SLE) and/or when a patient will experience a lupus flare. New data suggest myeloid cells in SLE patients skew B and T cell activation status toward the M1 state, thereby directing flares and remission. The genomic signatures of myeloid cells appear to correlate with and successfully predict SLE disease activity. Although altered myeloid cells gene expression is characteristic of both active and inactive SLE, disease activity was associated with a shift in myeloid cell activation toward the M1 proinflammatory phenotype. The research by Adam C. Labonte, PhD, staff scientist at AMPEL BioSolutions LLC, Charlottesville, Va., and colleagues was published in PLoS One.1
Read more: https://www.the-rheumatologist.org/article/alterations-in-macrophage-activation-may-signal-a-lupus-flare/
AMPEL BioSolutions had the privilege of being a part of Virginia’s first Life Sciences Workforce Summit which was held in Richmond on June 21, 2018. The event, sponsored by Virginia BIO, was held at the Virginia Museum of Fine Arts and was attended by about 125 representatives from academia, business and economic development organizations. Nearly every university, four-year college and community college in the Commonwealth attended the meeting, as well as all of the major life science businesses and several smaller ones.
AMPEL was represented by Audrey Ogendi, Clinical Operations Associate, who presented on a panel of young professionals who spoke about their experiences entering the work force and how well they felt they were prepared.
AMPEL Co-Founder and COO, Amrie Grammer said, “AMPEL promotes a culture that places great value on the talent development of all of our employees and Audrey is a great example of how dedication to continuing education can lead into a successful career in the life sciences industry. We were pleased to have her participate in the Virginia Bio Life Science Workforce Summit as a strong representative for AMPEL and our culture of promoting continuing education and workforce development.”
Audrey, who was recently admitted into Michigan State School of Medicine, is a Gates Millennium Scholar and a 2017 Masters in Public Health graduate of the University of Virginia, where she also received her 2015 BA in Women, Gender, and Sexuality. She is proficient in Swahili, Spanish and Kisii. During her undergraduate years, Audrey did independent research with Dr. Linda Columbus following the kinetics of thermophilic organisms and characterizing their coupling enzymes. Additionally, she received funding from the Jefferson Center for Global Health for her plan to travel to Limpopo, South Africa to develop an early childhood development program with culturally accepted assessment tools. She presented her results at the Consortium of Universities for Global Health in 2015. Audrey is proficient in Statistical Analysis Software (SAS) and joined AMPEL in 2017 to assist with the creation of an online learning tool to teach lupus patients and the clinicians that care for them about the details of small, proof-of-concept clinical trials testing the efficacy of drugs repositioned for lupus.